Commentary
The majority of NAFLD patients die of cardiovascular disease. For this reason, management of this condition requires a multidisciplinary team.
However, important misconceptions remain among primary care providers. NAFLD should be understood as part of a systemic disease characterized for abnormal accumulation of fat in tissues other than the adipose tissue, which produces organ dysfunctions.
This review by E. Godinez-Leiva et al. (University of Alabama, Birmingham, USA) “focuses on the extrahepatic manifestations of NAFLD and its metabolic and cardiovascular implications.”
